Alchemy Labs Inc.
ALCH.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | |||
|---|---|---|---|---|---|
| Revenue | -33.66% | -95.93% | 10.30% | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -33.66% | -95.93% | 10.30% | ||
| Cost of Revenue | -31.60% | -13.34% | 5.04% | ||
| Gross Profit | -37.18% | -610.79% | 26.91% | ||
| SG&A Expenses | 48.62% | -30.30% | 79.49% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -184.57% | 4.21% | 40.00% | ||
| Total Operating Expenses | 11.16% | -14.35% | 37.93% | ||
| Operating Income | -42.36% | -22.89% | -57.87% | ||
| Income Before Tax | -156.66% | -179.74% | -110.85% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -156.66% | -179.74% | -110.44% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -156.66% | -179.74% | -110.44% | ||
| EBIT | -42.36% | -22.89% | -57.87% | ||
| EBITDA | -43.05% | -21.53% | -60.15% | ||
| EPS Basic | -156.35% | -181.31% | -94.27% | ||
| Normalized Basic EPS | -156.64% | -180.65% | -94.17% | ||
| EPS Diluted | -156.35% | -157.87% | -94.27% | ||
| Normalized Diluted EPS | -156.64% | -180.65% | -94.17% | ||
| Average Basic Shares Outstanding | 0.10% | -0.45% | 8.49% | ||
| Average Diluted Shares Outstanding | 0.10% | -0.45% | 8.49% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||